GABA+
GABA+, licence 80144453: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Maysense CalmDeep
- Licence holder
- MAYSENSE INTERNATIONAL HOLDINGS LTD.
- NPN or DIN-HM
- 80144453
- Status
- Active licence
- Licence date
- 26 September 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1250 mg | 125.0 mg | Not calculated |
| Acide 4-aminobutanoïque Source : gamma-Aminobutyric acid | 150.0 mg | Not calculated |
| L-théanine Source : Camellia sinensis - feuille | 100.0 mg | Not calculated |
| L-théanine Source : L-Théanine | 100.0 mg | Not calculated |
Non-medicinal ingredients
Phosphate de calcium dibasique, Cellulose microcristalline, Carboxyméthyl cellulose de sodium, hydrolysée par action enzymatique, Stéarate de magnésium, Hydroxypropylcellulose, Croscarmellose de sodium, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps (to) temporarily promote relaxation. Withania somnifera is traditionally used in Ayurveda for memory enhancement. Withania somnifera is traditionally used in Ayurveda to help relieve restlessness and/or nervousness which helps to) promote sleep). Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress over time (e.g. in case of mental and physical fatigue related to stress).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144453
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.